Nakanishi Inc.

7716.T
Medical Instruments & Supplies
2026/04/03 Updated
Market Cap: $1.4B (¥227.5B)
Stock Price: $17.26 (¥2,740)
Exchange Rate: 1 USD = ¥158.73

Notice Regarding Status of Share Buyback (Buyback of Treasury Stock Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)

During the period from March 1, 2026 to March 31, 2026, Nakanishi Inc. did not conduct any share buybacks, resulting in 0 shares acquired and a total acquisition amount of 0 yen.

Importance:
Page Updated: April 1, 2026
IR Disclosure Date: April 1, 2026

Key Figures

  • Total Number of Shares Acquired: 0 shares (as of March 31, 2026)
  • Total Acquisition Amount: 0 yen (as of March 31, 2026)
  • Maximum Number of Shares to be Acquired: 1,500,000 shares (per Board of Directors resolution)

AI要約

Overview of Capital Policy

Nakanishi Inc. announced its policy to implement a share buyback pursuant to the resolution of the Board of Directors on February 12, 2026, in accordance with Article 165, Paragraph 3 of the Companies Act. The maximum number of shares to be acquired is set at 1,500,000 shares, the maximum acquisition price is 2,500,000,000 yen, and the acquisition period is from February 13, 2026 to December 30, 2026. However, as of March 31, 2026, no shares have been acquired and the acquisition amount remains at 0 yen, indicating that no share buybacks have been conducted during the period.

Impact on Shareholders and Future Outlook

Since no share buybacks have been executed to date, there has been no direct impact on dilution control or capital efficiency improvement for shareholders. The acquisition period continues until December 30, 2026, and future buyback activity may influence shareholder returns and capital policy trends. Investors should continue to monitor reports on the status of acquisitions closely.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.